Effect of CYP2D6 genetic polymorphism on peak propafenone concentration: no significant effect of CYP2D6*10

Doki, K; Shirayama, Y; Sekiguchi, Y; Aonuma, K; Kohda, Y; Ieda, M; Homma, M

PHARMACOGENOMICS, 2020; 21 (18): 1279

Abstract

Aim: The study aims to investigate the clinical implication of nonfunctional poor metabolizer (PM) alleles and intermediate metabolizer (IM) alleles o......

Full Text Link